CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HanulBNC Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HanulBNC Co Ltd
1412
92, Jomaru-ro 385beon-gil, Wonmi-gu
Phone: +82 326837903p:+82 326837903 BUCHEON, 14558  South Korea Ticker: 214870214870
Business Summary
HanulBNC Co Ltd, formerly NewGLab Pharma Co Ltd, is a Korea-based company principally engaged in the mobile distribution business. The Company is mainly engaged in the smartphone distribution business. The Company also manufactures and sells closed-circuit television cameras. In addition, the Company develops new drugs. Besides, the Company is engaged in the provision of cosmetic products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
5722 Household appliance stores
3663 Radio and television broadcasting and communications equipment
3669 Communications equipment, not elsewhere classified
2844 Perfumes, cosmetics, and other toilet preparations
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Vice President, Director Myeong JinKim 48 3/22/2023 3/22/2023
Internal Auditor Han SuLee 46
Internal Auditor Dong HuiLiu 44 11/30/2017 11/30/2017
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 172 (As of 6/30/2015)
Outstanding Shares: 9,351,889 (As of 6/30/2024)
Shareholders: 33,100
Stock Exchange: KDQ
Fax Number: +82 326837906


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024